Skip to main content
Premium Trial:

Request an Annual Quote

Cisbio to Offer BioTrove Screening Service

NEW YORK (GenomeWeb News) — Cisbio Bioassays will offer BioTrove's mass spectrometry screening service for assay development and drug screening to customers in the US, BioTrove said today.

Under the co-exclusive distribution agreement, Cisbio will offer BioTrove's RapidFire high-throughput service as a label-free detection method in conjunction with its Homogenous Time-Resolved Fluorescence, or HTRF technology and services. BioTrove will perform the RapidFire services at its screening facility.

HTRF is used for the detection of molecular interactions of proteins in vitro and is used for primary and secondary drug development screening.

Used together, the RapidFire and HTRF technologies will be used to study standard drug targets in the lead discovery phase and around 20 percent of drug targets that are difficult to study using fluorescent or radiolabel screening, BioTrove said.

"Cisbio's expertise in HTRF technology and significant sales presence among biopharma clients, combined with BioTrove's unique mass-spectrometry technology, will now provide customers access to a single, comprehensive source for drug discovery screening analysis," BioTrove President and CEO Al Luderer said in a statement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.